RBC Capital notes that Dyne Therapeutics (DYN) announced new clinical data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients ...
Seven-year-old Archie Ennis has been diagnosed with Duchenne muscular dystrophy, a genetic condition that causes muscle ...